Association of serum sodium minus chloride level at initiation of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and hyperkalemia in patients with CKD: a case control study

Association of serum sodium minus chloride level at initiation of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and hyperkalemia in patients with CKD: a case control study

Abstract Background Angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB) exert a renoprotective effect on patients with chronic kidney disease (CKD). Despite their benefit, one of their side effects is hyperkalemia, and it is one of the most common reasons for dis...

Full description

Bibliographic Details
Main Authors: Haruki Mae, Takuya Fujimaru, Koutarou Shimoyama, Nozomi Kadota, Kasumi Konishi, Yugo Itou, Masahiko Nagahama, Fumika Taki, Masaaki Nakayama
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Renal Replacement Therapy
Subjects:
Hyperkalemia
Metabolic acidosis
Angiotensin-converting enzyme inhibitor
Angiotensin receptor blocker
Chronic kidney disease
Online Access:https://doi.org/10.1186/s41100-024-00541-3

Internet

https://doi.org/10.1186/s41100-024-00541-3

Similar Items